Abstract: A method in which a mould is coated with a reactive polymer, a liquid curable composition is filled into the mould and cured under conditions such that the reactive polymer becomes covalently bonded to the cured bulk mould material at the interface. The reactive polymer has zwitterionic groups to confer improved biocompatibility on the moulded product. The reactive group on the reactive polymer is conveniently an ethylenically unsaturated group. The curable composition is suitably a radical polymerisable ethylenically unsaturated monomer mixture or a platinum-curable liquid silicone composition.

Abstract: A polymer is formed of ethylenically unsaturated monomers including a zwitterionic monomer, an aromatic monomer and a cross-linking monomer. Preferably the crosslinking monomer includes at least one a group containing compound and at least one aliphatic group containing compound. The polymer is water-swellable and a hydrogen has optical and mechanical properties rendering it suitable for use as an intraocular refractive device such as an intraocular lens.

Abstract: A glaucoma filtration implant is constituted by a generally tubular body section having an oblong external diameter formed of a continuous convex curve. The device preferably has flow resistance structure provided by a portion of the internal lumen having a reduced diameter. The flow resistance structure may have a length of up to 5000 &mgr;m and a diameter in the range 15 to 50 &mgr;m, the diameter being selected so as to achieve a pressure drop along the flow resistance structure in the range 5 to 15 mm Hg. The internal conduit for liquid flow also may include a removable flow inhibitor, which can be removed after implantation by a laser, such as an ophthalmic YAG laser. The device is made of biocompatible materials.

Abstract: Process for the free-radical polymerisation of olefinically unsaturated monomer(s) using a free-radical initiator, the polymerisation being performed in the presence of a compound for effecting molecular weight control, wherein the molecular weight control compound is a Co Il chelate of the following formula I ##STR1## wherein each group X, independently in each ring and in different rings, is a substituent selected from alkyl of 1 to 14 carbon atoms and cycloalkyl of 6 to 14 carbon atoms; n, independently in each ring, is 0 to 5 provided that in at least one ring, n is 1 to 5; Z, independently on each boron atom, is selected from F, Cl, Br, OH, alkoxy of 1 to 12 carbon atoms, aryloxy of 6 to 12 carbon atoms, alkyl of 1 to 12 carbon atoms, and aryl of 6 to 12 carbon atoms; or two Z groups taken together provide on one or both boron atoms a group --O--(Q)--O-- where Q is a divalent aryl or alicyclic linking group or an alkylene linking group, or two Z groups taken together on one or both boron atoms provide a

Abstract: Process for the free-radical polymerization of at least one olefinically unsaturated monomer, the polymerization being performed in the presence of a compound for effecting molecular weight control, being a CoII chelate of the following formula: ##STR1## wherein each group X is a divalent group which forms with the two carbon atoms to which it is bonded a pericondensed polycyclic group, being a group having 3 or more carbocyclic rings where the oxime-containing carbocyclic ring has carbon atoms in common with 2 or more of the other rings, the polycyclic group being unsubstituted (apart from the oxime groups) or having at least one hydrocarbyl substituent; and wherein each group Q is independently selected from F, Cl, Br, OH, C.sub.1-12 alkoxy, aryloxy, C.sub.